Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep;93(9):2161-2165.
doi: 10.1111/ans.18370. Epub 2023 Apr 20.

Acute diverticulitis in immunosuppressed patients: a 12-year management experience

Affiliations

Acute diverticulitis in immunosuppressed patients: a 12-year management experience

Navid Ahmadi et al. ANZ J Surg. 2023 Sep.

Abstract

Background: Diverticular disease of the colon occurs commonly in developed countries. Immunosuppressed patients are thought to be more at risk of developing acute diverticulitis, worse disease, and higher complications secondary to therapy. This study aimed to assess outcomes for immunosuppressed patients with acute diverticulitis.

Method: A retrospective single-centre review was conducted of all patients presenting with acute diverticulitis at a major tertiary Australian hospital from 2006 to 2018.

Result: A total of 751 patients, comprising of 46 immunosuppressed patients, were included. Immunosuppressed patients were found to be older (62.25 versus 55.96, p = 0.016), have more comorbidities (median Charlson Index 3 versus 1, P < 0.001), and undergo more operative management (13.3% versus 5.1%, P = 0.020). Immunosuppressed patients with paracolic/pelvic abscesses (Modified Hinchey 1b/2) were more likely to undergo surgery (56% versus 24%, P = 0.046), while in patients with uncomplicated diverticulitis, there was no difference in immunosuppressed patients undergoing surgery (6.1% versus 5.1% P = 0.815). Immunosuppressed patients were more likely to have Grade III-IV Clavien-Dindo complication (P < 0.001).

Conclusion: Immunosuppressed patients with uncomplicated diverticulitis can be treated safely with non-operative management. Immunosuppressed patients were more likely to have operative management for Hinchey 1b/II and more likely to have grade III/IV complications.

Keywords: colonic diverticular disease; colonic diverticulitis; elective surgery; emergent surgery; immunosuppression.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Strate LL, Morris AM. Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology 2019; 156: 1282-98 e1281.
    1. Serrano Gonzalez J, Lucena de la Poza JL, Garcia R, de Leon L et al. Diverticulitis in immunodeficient patients: our experience in the management of high-risk patients. Rev. Esp. Enferm. Dig. 2020; 112: 47-52.
    1. He S, Lu P, Etzioni D et al. Management of acute diverticulitis in immunocompromised patients-the Mayo Clinic experience. Dis. Colon Rectum. 2023; 66: 434-42.
    1. Brandl A, Kratzer T, Kafka-Ritsch R et al. Diverticulitis in immunosuppressed patients: a fatal outcome requiring a new approach? Can. J. Surg. 2016; 59: 254-61.
    1. McKechnie T, Lee Y, Kruse C et al. Operative management of colonic diverticular disease in the setting of immunosuppression: a systematic review and meta-analysis. Am. J. Surg. 2021; 221: 72-85.

LinkOut - more resources